As a common form of arthritis, osteoarthritis (OA) represents a degenerative disease, characterized by articular cartilage damage and synovium inflammation. Recently, the role of various microRNAs (miRs) and their specific expression in OA has been highlighted. Therefore, the aim of the current study was to elucidate the role by which miR-495 and chemokine ligand 4 (CCL4) influence the development and progression of OA. OA mice models were established, after which the CCL4 and collagen levels as well as cell apoptosis were determined in cartilage tissue of OA mice. The chondrocytes of the OA mice models were subsequently treated with a series of miR-495 mimic, inhibitor, and siRNA against CCL4. Afterwards, miR-495 expressions as well as the levels of CCL4, p50, p65, and IkBa and the extent of IkBa phosphorylation in addition to the luciferase activity of NF-kB were measured accordingly. Finally, cell apoptosis and cell cycle distribution were detected. miR-495 was highly expressed while NF-κB, CCL4, and collagen II were poorly expressed. Cell apoptosis was elevated in the cartilage tissue of the OA mice. CCL4 was a potential target gene of miR-495. Downregulation of miR-495 led to accelerated chondrocyte proliferation accompanied by diminished cell apoptosis among the OA mice. Taken together, the results of the current study demonstrated that inhibition of miR-495 suppressed chondrocyte apoptosis and promoted its proliferation through activation of the NF-κB signaling pathway by up-regulation of CCL4 in OA.
Introduction
As a chronic disease affecting nearly every joint in the human body, osteoarthritis (OA) is widely considered to be one of the foremost prevailing joint afflictions that markedly reduces quality of life [1] . Osteoarthritis is known to be progressive degenerative disease, characterized by an extensive degree of progressive damage to the articular cartilage which is accompanied by synovium inflammation [2] . The common term "wear and tear" has long been considered to be a characteristic consequence of OA that is represented by cartilage degradation [3] . A vast number of risk factors have been attributed to OA, including prior joint injury, obesity, and predisposing genetic elements have all been correlated with the development of OA, with aging being the most prominent factor [4] . OA has traditionally been regarded as a disease afflicting the elderly, however existing literature has revealed that the development of OA could start far earlier, with reports listing it as one of the top 20 diseases that may occur between the ages of 40-45 years [5] . Reports have indicated that approximately 9.6% of males and 18% of their female counterparts over the age of 60 years are affected by arthritis as a direct consequence associated with aging, with about 10% of people over the age of 55 reporting symptoms of painful and incapacitating knee OA [6] . OA has been reported to be a result of an increased matrix/collagen cross linking enzymes, which results in a stiffer matrix, with chondrocytes also identified to play a pivotal role in this process [7] .
A vast number of microRNAs (miRs), including miR-29, miR-141, miR-200a, miR-206, miR-210, and miR-2861, have been acknowledged as regulators of osteoblast genesis [8] . Furthermore, miR-140 was demonstrated to be specifically expressed in cartilage tissues, with recent literature highlighting miR-140 as a significant factor in the pathogenesis of OA [9] . A correlation between miR-107 and miR-449a and the members of chemokine ligand (CCL) has been identified by a recent study [10] . CCL4, commonly referred to as macrophage inflammatory protein-4 (MIP-4), and CCL2, represent potent attractors of the monocyte targeted by miR-33, which significantly impact immune responses providing blockade to infection and inflammation, which results in a distinct improvement in a variety of inflammatory diseases such as OA [11] . A number of family members such as CCL4, as well as CCL2, CCL18, and CCL20, have all been confirmed to be regulated via NF-κB signaling pathway [12] [13] [14] [15] . Studies have presented evidence that the NF-κB signaling pathway is strongly associated with OA owing to its promotion of OA chondrocyte apoptosis [16] . Furthermore, inactivation of the NF-κB signaling pathway has been demonstrated to be a positive factor in the cartilage destruction process of OA [17] . Based on the aforementioned exploration of literature, we subsequently aimed to investigate the effects of miR-495 on the regulation of chondrocyte viability and apoptosis in OA by regulating CCL4 as well as the NF-κB signaling pathway.
Results

CCL4 and collagen II are poorly expressed in cartilage tissues of OA mice
Initially, upon observation, the articular surface of mice in the OA group exhibited erosion or roughness, evident intraarticular synovial hyperplasia, markedly elevated synovial fluid, serious cartilage defect in addition to poorly organized cartilage tissue structure. Based on these observations, we subsequently concluded that the OA mouse model had been successfully established [18] . Immunohistochemical staining methods were performed in order to observe and evaluate the expression of CCL4 in the cartilage tissues of OA mice. CCL4 protein was noted to have brownish yellow granules, and mainly expressed in the nucleus. Both the positive rate and density of CCL4 in the cartilage tissues of the normal mice were significantly higher than those of OA mice (p < 0.05), suggesting the existence of low CCL4 expression in mice with OA ( Fig. 1) . Meanwhile, collagen II underwent immunohistochemical staining, the results of which demonstrated that the arthrosis section of OA mice presented with reduced collagen II expression (p < 0.05) compared with the normal mice, thus highlighting a decrease in the expression of CCL4 and collagen II in mice with OA.
Apoptosis of chondrocytes in cartilage tissues is increased in OA mice
Cell apoptosis among the cartilage tissues was detected through TUNEL staining in the cartilage tissues of both the control and OA groups. The results obtained indicated that the (Fig. 2 ) normal chondrocytes had a homogeneous distribution with no signs of obvious nuclei staining, approximately the same cell size, as well as a weakly 
CCL4 is a target gene of miR-495
Online analysis software was employed to ascertain as to whether CCL4 was indeed a target gene of miR-495. The results revealed that there was a specific binding region between 3′UTR of CCL4 gene and miR-495 sequence, and CCL4 was predicted as a target gene of miR-495 (Fig. 3a) . Dual-luciferase reporter gene assay was conducted in order to verify the prediction, the results of which revealed that in the miR-495 mimic group, luciferase signal transfected with CCL4 3′UTR was notably lower than that of the other groups (p < 0.05) (Fig. 3b) . The above findings indicated that miR-495 could specifically bind to CCL4-3′-UTR, which ultimately led to the downregulation of CCL4 expression following transcription.
miR-495 is overexpressed while CCL4 and NF-κB are poorly expressed in the cartilage tissues of OA mice
Next, RT-qPCR and western blot analysis were employed to in order to determine the expression of miR-495, CCL4, and NF-κB in the cartilage tissues following transfection. The results obtained indicated that the OA group had elevated miR-495 expression in the cartilage tissues, as well as a significant decrease in mRNA levels of CCL4 and NF-κB when compared with the control group (p < 0.05) (Fig. 4a) . Meanwhile, compared with the control group, the OA group demonstrated remarkably reduced protein levels of CCL4 and NF-κB in cartilage tissues (p < 0.05) (Fig. 4b ). These findings suggested that there was an upregulation of miR-495 while the expressions of CCL4 and NF-κB were downregulated in the OA mice. Meanwhile, western blot analysis was conducted in order to detect the protein levels of p50, p65, IkBa, and CCL4 as well as the extent of IkBa phosphorylation in each group after transfection (Fig. 6a, b) . Compared with the normal group, the blank, mimic-NC, inhibitor-NC, si-NC, miR-495 mimic, miR-495 inhibitor, siRNA-CCL4, and miR-495 inhibitor + siRNA-CCL4 groups presented with a decrease in the protein levels of CCL4, p50, and p65, and in the extent of IkBa phosphorylation, in addition to significantly elevated protein level of IkBa (all p < 0.05). When compared with the blank group, the mimic-NC, inhibitor-NC, si-NC and miR-495 inhibitor + siRNA-CCL4 groups exhibited no notable difference in relation to the protein levels among all the relative genes (p > 0.05), while the miR-495 mimic and siRNA-CCL4 groups demonstrated significantly decreased protein levels of CCL4, p50 and p65, as well as the extent of IkBa phosphorylation, and remarkably elevated protein level of IkBa (all p < 0.05); the miR-495 inhibitor group displayed a significant increase in the protein levels of CCL4, p50 and p65, and in the extent of IkBa phosphorylation, while the protein level of IkBa was markedly decreased (all p < 0.05). In comparison with the miR-495 inhibitor group, the miR-495 mimic, siRNA-CCL4 and miR-495 inhibitor + siRNA-CCL4 groups displayed a remarkable decrease in the protein levels of CCL4, , and p65, and in the extent of IkBa phosphorylation, while obviously enhanced protein levels of IkBa were noted (all p < 0.05). NF-kB luciferase activity was determined, the results ( Fig. 6c ) of which revealed there to be no significant difference between the blank group, and the mimic-NC, inhibitor-NC, si-NC and miR-495 inhibitor + siRNA-CCL4 groups (p > 0.05). NF-kB luciferase activity was reduced in the miR-495 mimic and siRNA-CCL4 groups, while elevated in the miR-495 inhibitor group (all p < 0.05). In comparison to the miR-495 inhibitor group, the miR-495 mimic, siRNA-CCL4 and miR-495 inhibitor + siRNA-CCL4 groups displayed decreased NF-kB luciferase activity (all p < 0.05). In conclusion, our results confirmed that miR-495 was involved in the regulation of CCL4 and inactivation of the NF-kB signaling pathway.
Inhibition of miR-495 promotes chondrocyte proliferation in OA mice
The effect of miR-495 and CCL4 on chondrocyte proliferation was investigated through the application of an MTT assay (Fig. 7) . At the 24th h time point, there was no significant difference in chondrocyte viability among blank, mimic-NC, inhibitor-NC, si-NC, miR-495 mimic, miR-495 inhibitor, siRNA-CCL4 and miR-495 inhibitor + siRNA-CCL4 groups (p > 0.05); at 48th and 72nd h time points, each group exhibited a remarkable difference. The remaining groups displayed reduced chondrocyte viability in comparison to the normal group (p < 0.05). When compared with the blank group, there was no obvious change The experiment was repeated three times independently; measurement data in normal distribution with homogeneous variance were analyzed by repeated measure analysis of variance. NC, negative control; OA, osteoarthritis; CCL4, chemokine ligand 4; miR-495, microRNA-495; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells observed in chondrocyte viability in the miR-495 mimic and siRNA-CCL4 groups exhibited impaired chondrocyte viability and the miR-495 inhibitor group presented with improved chondrocyte viability (p < 0.05). When compared with miR-495 inhibitor group, the miR-495 mimic, siRNA-CCL4 and miR-495 inhibitor + siRNA-CCL4 groups chondrocyte viability had been suppressed (p < 0.05). These finding demonstrated that chondrocyte viability was negatively influenced owing to the elevated levels of miR-495 and CCL4 silencing.
miR-495 inhibition reduces apoptosis of chondrocyte in OA mice
Flow cytometry was performed in order to evaluate the regulatory effect of miR-495 and CCL4 on chondrocyte apoptosis (Fig. 8) . In comparison with the normal group, the rate of apoptosis was significantly increased in the blank, mimic-NC, inhibitor-NC, si-NC, miR-495 mimic, miR-495 inhibitor, siRNA-CCL4 and miR-495 inhibitor + siRNA-CCL4 groups (p < 0.05), accompanied by a notable increase in the percentage of chondrocytes at the G0/G1 phase while a significant reduction in the percentage of chondrocytes in S phase (p < 0.05). Compared with the blank group, the mimic-NC, inhibitor-NC, and si-NC groups displayed no significant difference in the rate of apoptosis as well as the percentage of chondrocytes at the G0/G1 phase and S phase (p > 0.05), while the miR-495 mimic group and siRNA-CCL4 group exhibited a notably elevated apoptotic rate with an increased percentage of chondrocytes at the G0/G1 phase accompanied by a decreased percentage of chondrocytes at the S phase (p < 0.05); the apoptotic rate in the miR-495 inhibitor group was significantly decreased with a decrease in the percentage of chondrocytes at the G0/G1 phase, and an increase in the percentage of chondrocytes at the S phase (p < 0.05). Compared with the miR-495 inhibitor group, there was a significant increase in the rate of apoptosis in the miR-495 mimic, siRNA-CCL4 and miR-495 inhibitor + siRNA-CCL4 groups with an elevated percentage of chondrocytes at the G0/G1 phase accompanied by a decrease in the percentage of chondrocytes at the S phase (all p < 0.05). Thus, we concluded that the apoptosis of chondrocyte can be induced by miR-495 activation or CCL4 repression.
Discussion
Osteoarthritis represents one of the foremost debilitating degenerative diseases capable of affecting joints all around the body. The key findings of the current, present evidence demonstrating that the inhibition of miR-495 repressed chondrocyte apoptosis while acting to promote chondrocyte viability in OA through the up-regulating of CCL4 and activation of the NF-κB signaling pathway, highlighting its potential in the therapy of OA.
Our initial observations revealed that compared with the normal mice, OA mice showed lowly expressed CCL4 and highly expressed miR-495, suggesting the crucial role played by miR-495 and CCL4 in OA. Previous studies have revealed that more than one-third of human genes are regulated by miRNAs, with numerous studies implicating them in various processes such as the proinflammation, catabolism and anabolism of OA [19, 20] . Consistently, miRs, such as miR-140 and miR-146, have been shown to notably influence cartilage development, homeostasis and OA progression [9, 21, 22] . The overexpression of miR-140-5p, miR-125b-5p, miR-16, miR-223, miR-9, miR-98, and miR-30b in OA has also been previously documented [22, 23] . Meanwhile, in comparison with healthy subjects, the CCL22 protein displays elevated levels in rheumatoid arthritis (RA) and psoriatic arthritis (PsA) plasma [24] . CCL2 has also been determined to play a vital role in osteoclast genesis due to its ability to induce the recruitment of mononuclear cells, especially monocytes/macrophages, to sites of inflammation, which is a common symptom of OA [25] . Besides, dual-luciferase reporter gene assay verified that CCL4 was one of the target genes of miR-495. Similarly, miR-449a and miR-107 regulate CCL2 expression through the activation of the IL-6-mediated signaling cascade [10] . Reports have indicated that miR-133 could be a promising novel suppressor of CCL2 in chondrocytes, while further suggesting that the miR-33/CCL2 axis could potentially contribute to the regulation of monocyte chemotaxis in OA [26] .
In addition, we found that in comparison with the normal group, increased miR-495 expression accompanied by reduced mRNA levels of CCL4 and NF-κB was detected in the blank, mimic-NC, inhibitor-NC, si-NC, miR-495 mimic, miR-495 inhibitor, siRNA-CCL4, and miR-495 inhibitor + siRNA-CCL4 groups. Compared with the miR-495 inhibitor group, the miR-495 mimic group and the siRNA-CCL4 group displayed significantly increased expression levels of miR-495, while a contrasting trend was observed regarding the mRNA levels of CCL4 and NF-κB. Our study demonstrated that CCL4 mediated the NF-κB signaling pathway, resulting in the suppression of OA development. As a family of small proteins, chemokines possess the ability to recruit circulating leukocytes to sites of inflammation or injury based on the number and site of amino acid, and are allocated into four subfamilies, namely: CXC, CC, CX3C, and C [27] . CCL20 could promote osteoclast formation and osteoblast viability [28] . In the 5′ region of the CCL2 gene, NF-κB is one of the transcription factors of the binding sites [29] . Recent literature has demonstrated that the NF-κB signaling pathway could regulate the number of the CCL4 members, including CCL2, CCL18, CCL19, and CCL20 [13] [14] [15] 30] . For instance, chemokine expression of CCL22 has been shown to be enhanced by NF-κB activation in connection with NF-κB responsive elements [31] . The downregulation of NF-κB results in the inhibition of CCL27 [32] . Interestingly, studies have indicated that CCL4 intermediates can induce excessive reactive oxygen species (ROS) to function as signaling messengers to NF-κB, triggering an elevation in inflammatory cytokine production [33] .
Additionally, this study observed that compared with the normal group, the blank, mimic-NC, inhibitor-NC, si-NC, miR-495 mimic, miR-495 inhibitor, siRNA-CCL4, and miR-495 inhibitor + siRNA-CCL4 groups presented with a decrease in the protein levels of CCL4, p50 and p65, and in the extent of IkBa phosphorylation, in addition to significantly elevated protein level of IkBa. In comparison with the miR-495 inhibitor group, the miR-495 mimic, siRNA-CCL4 and miR-495 inhibitor + siRNA-CCL4 groups displayed a remarkable decrease in the protein levels of CCL4, p50, and p65, and in the extent of IkBa phosphorylation, while obviously enhanced protein levels of IkBa were noted. We made conclusion that the inhibition of miR-495 upregulated the protein levels of p50, p65, and the extent of IkBa phosphorylation, while downregulated protein levels of IkBa were observed, indicating the activation of the NF-κB signaling pathway. Additionally, p65 is a component of the NF-κB family of transcription factor, while p50 has been reported to be a product of p105, p100, p65 RelB, and c-Rel. Both p65 and p50 are essential in the regulation of gene expression in various mammalian cell types [34] . IkB is known as the inhibitor of NF-κB, whose degradation, ubiquitination and phosphorylation are caused by stimulated cells with inflammatory factors, carcinogens, and a Cell apoptosis and cell apoptotic rate after transfection in each group detected by flow cytometry; b cell cycle distribution and its comparison after transfection in each group detected by flow cytometry; *p < 0.05 vs. the normal group; #p < 0.05 vs. the blank group; &p < 0.05 vs. the miR-495 inhibitor group. The experiment was independently repeated three times; measurement data of cell apoptosis in normal distribution with homogeneous variance were analyzed by ANOVA; measurement data of cell distribution in normal distribution with homogeneous variance were analyzed by repeated measure analysis of variance. NC, negative control; OA, osteoarthritis; CCL4, chemokine ligand 4; miR-495, microRNA-495; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; ANOVA, one-way analysis of variance tumor enhancer [35] . Besides, NF-κB molecules belong to a family of ubiquitously expressed transcription factors, which have important effects on cell viability as well as cell death, and could potentially accelerate apoptosis of OA chondrocytes [16] . More importantly, reports have elucidated a link between NF-κB and OA [36] [37] [38] [39] . The NF-κB signaling pathway has been linked with the viability and apoptosis of osteoarthritis chondrocytes [40] . Activation of the NF-κB signaling pathway inhibits the interleukin-1β-induced apoptosis of chondrocytes in rat, which consequently prolongs the development of osteoarthritis [41] .
Notably, the study found that the blank, mimic-NC, inhibitor-NC, si-NC, miR-495 mimic, miR-495 inhibitor, siRNA-CCL4, and miR-495 inhibitor + siRNA-CCL4 groups displayed reduced chondrocyte viability, increased apoptosis in comparison to the normal group. Our study presents evidence demonstrating that the inhibition of miR-495 accelerates chondrocyte proliferation, while decreasing its apoptosis in OA mice by means of CCL4 regulation. Additionally, miR-495 has been reported to repress new bone regeneration and osteoblast differentiation as well as providing an element of restraint that stimulates osteoblasts differentiation and proliferation [42] . Reports have indicated that miR-29b-3p is associated with the pathogenesis and progression of OA as well as the enhancement of chondrocyte apoptosis, which was consistent the findings of the current study [43] . What is more, the depletion of miR-34a leads to enhanced chondrocyte proliferation while acting to suppress chondrocyte apoptosis in OA [44] . Speculation exists suggesting that miR-181 induces the acceleration of chondrocyte apoptosis and reduction of chondrocyte proliferation [45] . Taken together, the aforementioned findings provide elucidation regarding the role by which miR-495 acts as a contributor and CCL4 as an inhibitor in the process of chondrocyte proliferation and apoptosis in mice with OA.
In conclusion, our study provides evidence indicating that depleted miR-495 decreases chondrocyte apoptosis, while acting to enhance chondrocyte viability in OA, by means of elevating CCL4 and activating the NF-κB pathway. The key observations of our study offer a new insight into the therapeutic study of OA. However, further investigation is warranted into the underlying mechanisms of this regulatory function in the development of inflammation and oxidative stress.
Methods and materials
Ethics statement
Animal experimentation was performed in strict accordance with the guidelines for the Care and Use of Laboratory Animals. The study protocol was conducted under the approval by the Animal Care Committee of The Second Affiliated Hospital of Xi'an Jiaotong University.
Model establishment
Forty clean and healthy male mice (weighing within the range of 20-25 g) were purchased from the experimental animal center, Institute of Surgery Research, Daping Hospital, Third Military Medical University (Chongqing, China). The recruited mice were raised under controlled conditions and granted free access to food and water as well as natural light at a controlled room temperature of 18-22°C, relative humidity of 40-70%, and background noise maintained at less than 50 dB. Following one-week of adaptive feeding, the mice were randomly allocated into the control group (n = 20) and OA group (n = 20). Our OA mouse model was established by operative means, by surgically-inducing the destabilization of the medial meniscus (DMM). Once the OA model mice had been fixed and sterilized, their medial patellar tendon was incised with the use of microblade in order to expose the articular cavity. The fat pad of the femoral condyle was excised by means of blunt dissection in an attempt to expose the intercondylar area and to observe the tibial ligament of medial meniscus. Next, an incision was made on the tibial ligament of the medial meniscus using a microblade, after which the skin and tissues were sutured. The operation was performed with extra caution taken in order to avoid articular cartilage injury. Following the operation, the operative limbs were kept in an unfixed manner, with the mice permitted to move freely in the cage. The mice were administered penicillin through the application of an intraperitoneal injection (80,000 units/mouse, 0.1 mL, Sigma, St. Louis, MO, USA) for infection prophylaxis purposes. Mice in the control group received no treatment.
Immunohistochemical staining
The cartilage of the mice was sectioned in a conventional manner and dewaxed for immunohistochemical staining purposes. The slices were then placed in 3% H 2 O 2 for 10 min at room temperature, heated three times with a microwave, treated with an antigen retrieval buffer at room temperature for 10 min, and rinsed three times with 0.15 mol/L phosphate buffered solution (PBS) (2 min each). Normal goat serum was stored at room temperature for 20 min. Next, the slices were incubated with primary antibody rabbit anti-mouse chemokine ligand 4 (CCL4) (1: 100, bs-1046R, Beijing Bioss Biological Technology Co. Ltd., Beijing, China), and rat anti-mouse Collagen II (1: 100, ab185430, Abcam Inc., Cambridge, MA, USA) at 4°C overnight. Following two 0.15 mol/L PBS rinses (3 min each), the slices were incubated with goat antirabbit biotinylated immunoglobulin G (IgG) and goat antimouse biotinylated IgG (1:1000, Abcam Trade Co. Ltd., Shanghai, China) at 37°C for 20 min. The slices were then subsequently rinsed twice with 0.15 mol/L PBS (3 min each), incubated with strept avidin-biotin complex (SABC) at 37°C for 20 min, and rinsed three times with 0.15 mol/L PBS (4 min each). Next, the slices were developed by diaminobenzidine (DAB) (Sigma, St. Louis, MO, USA) for 5-10 min, rinsed fully with distilled water, slightly counterstained by hematoxylin (Sigma, St. Louis, MO, USA), dehydrated and mounted. Afterwards, five visual fields had been selected in a continuous fashion from each slice; the CCL4 protein expression was analyzed under a microscope, counted and photographed accordingly. The absence of positive number was considered to be negative, while a positive number of less than 10% was considered to be reflective of a low expression; a positive number higher than 10% but below 50% was considered to be highly expressed, and positive number of higher than 50% was regarded as a strong expression [46] . Collagen II protein expression was observed under a microscope, with the positive cells regarded as cartilage cells.
Terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick-end labeling (TUNEL) staining
TUNEL staining was conducted based on the instructions of the TUNEL kit (Beijing Dingguo Bio Technology Co., Ltd., Beijing, China). Prior to the operation, paraffinembedded sections were pretreated. Next, 10 μL of reaction solution containing 1 μL of enzyme and 9 μL of reaction buffer were added to the sections, rinsed by buffer A twice (1 min each), and treated with 50 μL sealing solution at 37°C for 30 min. The solution was then discarded. The sections were subsequently treated with 40 μL color development solution at 37°C for 60 min, rinsed twice with buffer B (1 min/time), and reacted with 40 μL 5-bromo-4-chloro-3-indolyl-phosphate/nitroblue tetrazolium (BCIP/NBT) color development solution at cassette for 20 min. If no background appeared, development could be continued. The sections were washed with buffer B twice (1 min/time), counterstained by nuclear fast red for 20 s, rinsed, dehydrated by gradient ethanol, cleared and mounted. The positive chondrocytes were considered as those with nucleus stained yellow. Six non-overlapping power fields (×200) were selected randomly from each section, with the percentage of the average positive cells calculated based on the following formula: apoptosis index (AI) = the number of apoptotic nuclei/total nucleus number × 100% [47] .
Dual-luciferase reporter gene assay
Databases microRNA.org, miRbase and Target Scan were all employed for the target gene analysis of miR-495 in an attempt to ascertain as to whether CCL4 was the direct target gene of miR-495. In order to confirm their target relationship, luciferase reporter vector recombinant plasmids pCCL4-wild type (Wt) with CCL4 3′-untranslated region (3′UTR) wild sequence and pCCL4-mutant (Mut) with CCL4 3′-UTR mutation sequence were constructed. The full-length of 3′UTR region of CCL4 gene was cloned and amplified. PCR products were cloned into the multiple cloning sites in the downstream of the luciferase gene pmirGLO (Promega, Madison, WI, USA). The binding site between miR-495 and the target gene was predicted by bioinformatic analysis and site-specific mutagenesis. Renilla luciferase-expressed promoter-Renilla luciferase reporter plasmid (pRL-TK) (TaKaRa, Dalian, Liaoning, China) was regarded as internal reference which was used to adjust the transfection efficiency difference and cell number. Next, the miR-495 mimic and miR-495 negative control (NC) were separately transfected with the luciferase reporter vector and inserted into the chondrocytes. The medium was absorbed following a 48 h period of transfection. After two PBS rinses, 100 μL passive lysis buffer (PLB) was added to the cells per well, and slightly shaken at room temperature for 15 min, after which the cell lysate was collected. Pre-reading of the program was set at 2 s with 10-s reading value, with 100 μL of LARII Stop & Glo® Reagent added on each occasion. The prepared LARII Stop & Glo® Reagent and the luminescent tube or plate with cell lysate (20 μL of each sample) were then placed into a bioluminescence detector. The program was run and after the fluorescent value was read, the data obtained were saved. The relative fluorescence was calculated according to the following formula: the relative fluorescence value = value of firefly luciferase activity/value of renilla luciferase activity. The experiment was conducted three times.
Reverse transcription quantitative polymerase chain reaction (RT-qPCR)
The miR-495, CCL4, NF-κB, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) primers (Table 1) were designed and synthesized using software Primer Premier 5.0 (TaKaRa, Dalian, Liaoning, China) based on the published corresponding mRNA sequence from the mice. The total RNAs of mice cartilage tissues and chondrocytes were extracted in each group in accordance with the instructions on the Trizol kit (Invitrogen Inc, Carlsbad, CA, USA). Afterwards, RNA was reversely transcribed into cDNA based on the instructions of the PrimeScript RT kit (TaKaRa, Dalian, Liaoning, China). The reverse transcription system was 10 μL and the reaction conditions were comprised of reverse transcription reaction at 37°C for 45 min, and reverse transcriptase inactivation reaction at 85°C for 5 s. The reaction mixture was then collected for fluorescent quantitative PCR based on the instructions of the SYBR ® Premix Ex Taq TM II Kit (TaKaRa, Dalian, Liaoning, China). A total of 50 μL reaction system was as follows: 25 μL SYBR ® Premix Ex Taq TM II (2×), 2 μL PCR forward primer, 2 μL PCR reverse primer, 1 μL roxithromycin (ROX) Reference Dye (50×), 4 μL DNA template and 16 μL ddH 2 O. Fluorescence quantitative PCR was conducted in the ABI PRISM ® 7300 system (ABI, San Diego, CA, USA), while reverse transcription and amplification processes were both performed in accordance with instructions on the kits. The reaction conditions were as follows: pre-denaturation at 95°C for 30 s, a total of 40 cycles of denaturation at 95°C for 5 s, and annealing and extension at 60°C for 30 s. U6 was regarded as the internal reference of miR-495 while GAPDH was considered to be the internal reference of the remaining genes. According to computed tomography (CT) value displayed using a PCR instrument. The 2 -ΔΔCt method was employed in order to determine the respiratory quotient (RQ) value, followed by a statistical analysis of the differential expression of the relative genes from the two groups. The experiment was conducted three times. The aforementioned methods were also applicable during the in vitro/cell experiments.
Western blot analysis
Cartilage tissues were treated in liquid nitrogen, and ground uniformly into fine powder. Next, protein lysate (Solarbio Technology Co., Ltd., Beijing, China) was added to the tissues, and centrifugated at 25,764 × g at 4°C for 20 min. The supernatant was separated and kept for later experimentation. After lysis and water bathing at 100°C for 10 min, the protein was electrophoresed in 10% sodium dodecyl sulfate (SDS)-polyacrylamide gel at 80 V for 30 min and at 100 V for 90 min, followed by transfer from the gel onto the nitrocellulose membrane with pore size of 0.2 mol/L at 200 mA for 120 min. The membrane was immersed in 1× Tris-buffered saline Tween 20 (TBST) solution containing 50 g/L of skim milk at room temperature with gentle shaking for 1 h to block the non-specific binding sites. Following treatment with 1× TBST three times (5 min each), the membrane was incubated with primary antibodies rabbit anti-mice CCL4 (1:100, bs-1046R, Bioss Biological Technology Development Co. Ltd, Beijing, China), IkBa (#4812, Cell Signaling Technology, Danvers, MA, USA), p65 (#8242, Cell Signaling Technology, Danvers, MA, USA) and p50 (0.5 μg/mL, #12540, Cell Signaling Technology, Danvers, MA, USA) in a 4°C refrigerator overnight, after which the primary antibodies were removed. The membrane was then treated with 1× TBST three times (5 min each), and incubated with secondary antibody horseradish peroxidase (HRP)-labeled goat anti-rabbit (1:1000, Shanghai YuSen Biotechnology Co. Ltd., Shanghai, China) at room temperature for 2 h. Afterwards, the secondary antibody was removed and the membrane was rinsed with 1× TBST three times, and immersed in electrochemiluminescence (ECL) reaction solution at room temperature for 1 min. Once the surface moisture was absorbed, the membrane was covered with preservative film, exposed in a dark room, developed and fixed, after which the results were observed. With GAPDH (1:1000, Sigma, Sigma, St. Louis, MO, USA) as internal reference, the gray value ratio of the target band to internal reference bands was regarded as the relative levels of protein. The method was also suitable for in vitro experiment or cell experiments. The experiment was conducted three times independently.
Cell culture, grouping, and transfection
The OA and normal mice (Beijing Weitonglihua Experimental Animal Technology Co. Ltd., Beijing, China) were decollated, with cartilage of bilateral knee cut off following sterilization. Next, the cartilage was rinsed with low glucose-Dulbecco's modified eagle's medium (L-DMEM, Gibco, Grand Island, NY, USA) three times, cut into about 1 mm 3 cubes and rinsed with L-DMEM again. Afterwards, 1 g/L collagenase II (Sigma, St. Louis, MO, USA) was added in a different culture medium, with the cartilage cubes placed inside. Next, the mixed medium was cultured in a 37°C incubator (Heal Force HF90, Hongkong Heal Force Biological and Medical Technology Group, Hongkong, China) for 4 h. The cell suspension, which had 6 cells/mL). The cells were then grouped into normal (normal mice chondrocytes without any treatment), blank (OA mice chondrocytes transfected with no sequence), mimic-NC (OA mice chondrocytes transfected with miR-mimic control NC sequence), inhibitor-NC (OA mice chondrocytes transfected with miR-inhibitor control NC sequence), si-NC (OA mice chondrocytes transfected with siRNA control NC sequence), miR-495 mimic (OA mice chondrocytes transfected with miR-495 mimic sequence), miR-495 inhibitor (OA mice chondrocytes transfected with miR-495 inhibitor sequence), siRNA-CCL4 (OA mice chondrocytes transfected with siRNA sequence against CCL4) and miR-495 inhibitor + siRNA-CCL4 (OA mice chondrocytes cotransfected with siRNA sequence against CCL4 and miR-495 inhibitor) groups. Cells exhibiting logarithmic growth were inoculated into a 6-well plate. When cell confluence reached 30-50%, the cells were transfected in accordance with the instructions on the Lipofectamine 2000 kit (Invitrogen Inc, Carlsbad, CA, USA). miR-495 mimic, mimic-NC, siRNA-CCL4, miR-495 inhibitor, miR-495 inhibitor + siRNA-CCL4 (transfection sequence of siRNA-CCL4 was 5′-AACTCCAGCTCCTACTACTACAGC-3′, synthesized by Shanghai GenePharma Ltd. Company, Shanghai, China) and NC lyophilized powder (Invitrogen, Car, Cal, USA) were dissolved with RNase-free water following centrifugation. Afterwards, 5 μL of lipofectamine 2000 was diluted with 250 μL serum-free Opti-MEM (Gibco, Carlsbad, CA, USA), mixed in a gentle manner and cultured at room temperature for 5 min. Once the above solutions were mixed, the mixture was cultured at room temperature for 20 min, and added to the cell culture wells. Subsequently, the cells were incubated at 37°C with 5% CO 2 for 6-8 h, after which incubation was performed in a complete medium for 24-48 h for subsequent experiments.
NF-kB luciferase activity assay
Activation of the NF-kB signaling pathway was detected with the use of NF-kB luciferase activity assay. Chondrocytes at the logarithmic growth phase were collected, with the monolayer cultured cells detached by 0.25% trypsin. Next, a reaction took place between the cells and a Roswell Park Memorial Institute (RPMI) 1640 medium (Shanghai Fusheng Industrial Co., Ltd., Shanghai, China) containing 10% FBS to make 2.5 × 10 5 cells/mL suspension. The cell suspension was then inoculated into a 96-well plate with 8 parallel wells set in each group (100 μL suspension per well), and incubated at 37°C with 5% CO 2 . Following a 48-h period of transfection, NF-kB luciferase activity was determined using a dual-luciferase detection kit (Promega Corporation, Madison, WI, USA). The experiment was repeated three times.
3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-Htetrazolium bromide (MTT) assay
Chondrocytes at the logarithmic growth phase were collected, with monolayer cultured cells detached by 0.25% trypsin. RPMI 1640 medium (Shanghai FuSheng Industrial Co, Ltd, Shanghai, China) containing 10% FBS was utilized to make a 2.5 × 10 5 cells/mL cell suspension, which was then seeded into a 96-well plate. According to the experiment grouping, 8 parallel wells (100 μL/well) were set in each group. Incubation was then carried out at 37°C and with 5% CO 2. The plate was then removed at 24 h, 48 h, 72 h respectively, after which each well was added with 10 μL of 5 mg/mL MTT reagent (Sigma, St. Louis, MO, USA) for 4-h further incubation. The optical density (OD) of each well was measured at a wavelength of 570 nm using an automatic microplate reader (Bio-Rad Inc., Hercules, CA, USA). Each experiment was repeated three times.
Flow cytometry
Following a 48-h period of transfection, the chondrocytes in each group were collected, and centrifugated at 1610×g for 8 min to prepare single cell suspension. After the supernatant was discarded, the cell suspension was incubated with 1 × 300 μL binding buffer and 5 μL Annexin Vfluorescein isothiocyanate (FITC) (Sigma, St. Louis, MO, USA) under conditions void of light at room temperature for 15 min. The cell suspension was then added with 5 μL propidium iodide (PI) and 200 μL 1× binding buffer 5 min before detection. Flow cytometry (FACSCalibur, Beckman Coulter, Miami, FL, USA) was employed for the analysis of cell apoptosis. In the scatter plot of cell apoptosis: the lower left quadrant represented normal cells (An-PI−); the lower right quadrant represented apoptotic chondrocytes in early stage (An+ PI−); the upper right quadrant represented apoptotic chondrocytes in advanced stage and necrotic chondrocytes (An+ PI+); and the upper left quadrant represented damaged chondrocytes in the process of collection (An-PI+). The rate of apoptosis was expressed as the percentage of the early apoptotic chondrocytes in the total number of chondrocytes. The experiment was conducted three times.
After transfection for 48 h, the chondrocytes in each group were collected, and centrifugated at 1789 × g for 5 min, after which the supernatant was discarded. Next, the cells were rinsed twice with PBS, resuspended with cell concentration adjusted to about 1 × 10 6 cells/mL, fixed in 1 mL of 75% ethanol which was pre-cooled at −20°C at 4°C for 1 h, and centrifuged. Following removal of the cold ethanol, the cells were rinsed twice with PBS, after which the supernatant was discarded. The cells were then subsequently added with 100 mL RNase A (Sigma, St. Louis, MO, USA) under conditions void of light, water-bathed at 37°C for 30 min, and completely stained with 400 μL PI (Sigma St. Louis, MO, USA) under dark conditions at 4°C for 30 min. The cells were then filtered using a 200-mesh filter, and a total of 10,000 chondrocytes were detected and counted accordingly. Cell cycle was detected by flow cytometry. The content distribution curve of DNA was obtained by measuring the DNA content of each cell in the cell groups. The experiment was repeated three times. The ordinate of cell cycle distribution map represented the number of effective chondrocytes, while abscissa indicated DNA content.
Statistical analysis
Data analysis was conducted using SPSS 21.0 software (IBM Corp. Armonk, NY, USA). Measurement data were expressed as mean ± standard deviation. The comparison between two groups was performed using a student t-test, while the comparison among multiple groups was conducted using one-way analysis of variance (ANOVA). Kolmogorov-Smirnov method was used to test the normality of data. Data with normal distribution were compared using ANOVA with Tukey method for post-test, while data with a partial distribution were examined using a non-parametric test Kruskal-Wallis with Dunn's multiple comparison for post-test. p < 0.05 was indicative of a statistically significant value.
